Ref ID: 19382
Author:
M. Hoenigl,1 W. Duettmann,1 C. Koidl,1 B. Waitzl,1 B. Sartori,2
K. Seeber,1 M. Lackner,2 V. Posch,1 W. Buzina,1 A. W€olfler,1
R. Krause,1 C. Thornton3 and C. Lass-Florl2
Author address:
1Medical University of Graz, Austria; 2Innsbruck Med. University,
Austria and 3Univ. of Exeter, United Kingdom
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Abstract:
Background Timely diagnosis is a key factor in successful treatment
of invasive pulmonary aspergillosis (IPA). Limitations of galactoman-
nan (GM) testing are varying turnaround time and availability.
These limitations may be overcome by the Lateral- Flow Device (LFD)
test, a single sample point-of-care test that is based on the detection
of an Aspergillus extracellular glycoprotein antigen by monoclonal
antibody JF5. This study evaluates the LFD test by using bronchoal-
veolar lavage (BAL) samples.
Methods A total of 173 BAL samples from 167 patients that were
tested routinely for GM between between 2011 and 2013 at the
Austrian University Hospitals of Graz (98 samples) and Innsbruck
(75 samples) were included. 53 had probable/proven, 52 possible,
and 68 no IPA. Diagnostic accuracy of LFD for probable/proven IPA
was evaluated. For IPA grading fungal cultures as well as BAL GM
(cut-off 1.0) were used.
Results Sensitivity and specificity of LFD test for probable/proven
IPA were 75.5% and 84.2%, respectively (Graz: 95% and 84%;
Innsbruck: 63% and 84%). PPV was 68%, NPV 89%. BAL GM lev-
els were available in 108 samples (98 from Graz, 10 from Inns-
bruck) and significantly lower in patients with negative than in
those with positive LFD result (P < 0.0001). LFD resulted negative
in 13 patients with probable IPA. BAL GM was tested in two of
those only and revealed levels of 1.23 and 1.35. LFD resulted posi-
tive in a total of 15 patients with possible and 4 without IPA
(weakly to moderately positive LFD result in 17/19 cases). In 7 of
these cases corresponding GM values were between 0.6 and
0.7.LFD resulted negative in proven/probable cases of infection due
to Mucorales, Scedosporium spp., Fusarium spp., and Cryptococcus
neoformans.
Conclusions The LFD test of BAL specimens is performed easily and
provides accurate and rapidly available results. Therefore, this new
point-of-care test may be a very promising diagnostic approach for
detecting IPA in BAL specimens.
Abstract Number: p044
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a